OpenURL Connection Search

Select item for more details and to access through your institution.

The Effect of Erythromycin on the Disposition Kinetics of Warfarin.
Published in:
Pharmacology, 1984, v. 28, n. 3, p. 171, doi. 10.1159/000137958
By:
- Bachmann, Kenneth;
- Schwartz, Jules I.;
- Forney, Jr., Robert;
- Frogameni, Anthony;
- Jauregui, Luis E.
Publication type:
Article
Inhibition of prostacyclin and thromboxane biosynthesis in healthy volunteers by single and multiple doses of acetaminophen and indomethacin.
Published in:
Clinical Pharmacology in Drug Development, 2015, v. 4, n. 5, p. 337, doi. 10.1002/cpdd.194
By:
- Schwartz, Jules I.;
- Musser, Bret J.;
- Tanaka, Wesley K.;
- Taggart, William V.;
- Mehta, Anish;
- Gottesdiener, Keith M.;
- Greenberg, Howard E.
Publication type:
Article
Comparative Pharmacokinetics of Lovastatin, Simvastatin and Pravastatin in Humans.
Published in:
1992
By:
- Pentikainen, Pertti J.;
- Saraheimo, Markku;
- Schwartz, Jules I.;
- Amin, Raju D.;
- Schwartz, Michael S.;
- Brunner-Ferber, Francoise;
- Rogers, J. Douglas
Publication type:
Other
The bioavailability and nonlinear pharmacokinetics of MK-679 in humans.
Published in:
Biopharmaceutics & Drug Disposition, 1994, v. 15, n. 5, p. 409, doi. 10.1002/bdd.2510150507
By:
- Cheng, Haiyung;
- Schwartz, Jules I.;
- Lin, Charles;
- Amin, Raju D.;
- Seibold, James R.;
- Lasseter, Kenneth C.;
- Ebel, David L.;
- Tocco, Dominick J.;
- Rogers, J. Douglas
Publication type:
Article
The effect of rofecoxib on the pharmacodynamics and pharmacokinetics of warfarin*.
Published in:
Clinical Pharmacology & Therapeutics, 2000, v. 68, n. 6, p. 626, doi. 10.1067/mcp.2000.112244
By:
- Schwartz, Jules I.;
- Bugianesi, Kathleen J.;
- Ebel, David L.;
- De Smet, Marina;
- Haesen, Rita;
- Larson, Patrick J.;
- Ko, Amy;
- Verbesselt, Rene;
- Hunt, Thomas L.;
- Lins, Robert;
- Lens, Simone;
- Porras, Arturo G.;
- Dieck, John;
- Keymeulen, Bart;
- Gertz, Barry J.
Publication type:
Article
Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans*.
Published in:
Clinical Pharmacology & Therapeutics, 1999, v. 65, n. 6, p. 653, doi. 10.1016/S0009-9236(99)90087-5
By:
- Schwartz, Jules I.;
- Chan, Chi-Chung;
- Mukhopadhyay, Saurabh;
- McBride, Kathleen J.;
- Jones, Terry M.;
- Adcock, Sherilyn;
- Moritz, Carl;
- Hedges, Jerris;
- Grasing, Kenneth;
- Dobratz, David;
- Cohen, Robert A.;
- Davidson, Michael H.;
- Bachmann, Kenneth A.;
- Gertz, Barry J.
Publication type:
Article
Pharmacodynamics of MK-0963, a new 5α-reductase inhibitor: Effects on serum androgen concentrations.
Published in:
Clinical Pharmacology & Therapeutics, 1994, v. 55, n. 1, p. 50, doi. 10.1038/clpt.1994.9
By:
- Schwartz, Jules I;
- Laskin, Oscar L;
- Meeter, Carol A;
- Patterson, Patricia M;
- Schneider, Stephen H;
- Lasseter, Kenneth C;
- Seibold, James R
Publication type:
Article
Effect of MK-386, a Novel Inhibitor of Type 15~ Reductase, Alone and in Combination with Finasteride, on Serum Dihydrotestosterone Concentrations in Men.
Published in:
Journal of Clinical Endocrinology & Metabolism, 1996, v. 81, n. 8, p. 2942, doi. 10.1210/jc.81.8.2942
By:
- SCHWARTZ, JULES I.;
- VAN HECKEN, ANNE;
- DE SCHEPPER, PAUL J.;
- DE LEPELEIRE, INGE;
- LASSETER, KENNETH C.;
- SHAMBLEN, E. COOPER;
- WINCHELL, GREGORY A.;
- CONSTANZER, MARVIN L.;
- CHAVEZ, CYNTHIA M.;
- WANG, DANIEL Z.;
- EBEL, DAVID L.;
- JUSTICE, STEVEN J.;
- GERTZ, BARRY J.
Publication type:
Article
Evaluation of the pharmacokinetics of digoxin in healthy subjects receiving etoricoxib.
Published in:
British Journal of Clinical Pharmacology, 2008, v. 66, n. 6, p. 811, doi. 10.1111/j.1365-2125.2008.03285.x
By:
- Schwartz, Jules I.;
- Agrawal, Nancy G. B.;
- Wehling, Martin;
- Musser, Bret J.;
- Gumbs, Carol P.;
- Michiels, Nicole;
- De Smet, Marina;
- Wagner, John A.
Publication type:
Article
Pharmacokinetic Evaluation of Rofecoxib: Comparison of Tablet and Suspension Formulations.
Published in:
Clinical Drug Investigation, 2003, v. 23, n. 8, p. 503, doi. 10.2165/00044011-200323080-00002
By:
- Schwartz, Jules I.;
- Larson, Patrick J.;
- Porras, Arturo G.;
- Viswanathan-Aiyer, Kala-Jyoti;
- Agrawal, Nancy G.B.;
- Lasseter, Kenneth C.;
- Mazenko, Ralph S.;
- Merschman, Sheila A.;
- Gertz, Barry J.
Publication type:
Article
Examination of the Effect of Increasing Doses of Etoricoxib on Oral Methotrexate Pharmacokinetics in Patients With Rheumatoid Arthritis.
Published in:
Journal of Clinical Pharmacology, 2009, v. 49, n. 10, p. 1202, doi. 10.1177/0091270009338939
By:
- Schwartz, Jules I.;
- Agrawal, Nancy G. B.;
- Wong, P. H.;
- Miller, Jutta;
- Bachmann, Kenneth;
- Marbury, Thomas;
- Hoelscher, David;
- Cavanaugh Jr., Paul F.;
- Gottesdiener, Keith
Publication type:
Article
Influence of Taranabant, an Orally Active, Highly Selective, Potent Cannabinoid-1 Receptor (CB1R) Inverse Agonist, on Ethinyl Estradiol and Norelgestromin Plasma Pharmacokinetics.
Published in:
Journal of Clinical Pharmacology, 2009, v. 49, n. 1, p. 72, doi. 10.1177/0091270008325930
By:
- Schwartz, Jules I.;
- Dunbar, Stephanie;
- Yuan, Jinyu;
- Li, Susie;
- Miller, Deborah L.;
- Rosko, Kim;
- Johnson-Levonas, Amy O.;
- Lasseter, Kenneth C.;
- Wagner, John A.
Publication type:
Article
Comparative Inhibitory Activity of Etoricoxib, Celecoxib, and Diclofenac on COX-2 Versus COX-1 in Healthy Subjects.
Published in:
Journal of Clinical Pharmacology, 2008, v. 48, n. 6, p. 745, doi. 10.1177/0091270008317590
By:
- Schwartz, Jules I.;
- Dallob, Aimee L.;
- Larson, Patrick J.;
- Laterza, Omar F.;
- Miller, Jutta;
- Royalty, Jane;
- Snyder, Karen M.;
- Chappell, Derek L.;
- Hilliard, Deborah A.;
- Flynn, Mary F.;
- Cavanaugh Jr., Paul F.;
- Wagner, John A.
Publication type:
Article
Effects of Etoricoxib and Comparator Nonsteroidal Anti-Inflammatory Drugs on Urinary Sodium Excretion, Blood Pressure, and Other Renal Function Indicators in Elderly Subjects Consuming a Controlled Sodium Diet.
Published in:
Journal of Clinical Pharmacology, 2007, v. 47, n. 12, p. 1521, doi. 10.1177/0091270007307878
By:
- Schwartz, Jules I.;
- Thach, Chau;
- Lasseter, Kenneth C.;
- Miller, Jutta;
- Hreniuk, David;
- Hilliard, Deborah A.;
- Snyder, Karen M.;
- Gertz, Barry J.;
- Gottesdiener, Keith M.
Publication type:
Article
Pharmacokinetics of Etoricoxib in Patients with Renal Impairment.
Published in:
Journal of Clinical Pharmacology, 2004, v. 44, n. 1, p. 48
By:
- Nancy G. B. Agrawal;
- Catherine Z. Matthews;
- Ralph S. Mazenko;
- Walter F. Kline;
- Eric J. Woolf;
- Arturo G. Porras;
- Leslie A. Geer;
- Peggy H. Wong;
- Meehung Cho;
- Josee Cote;
- Thomas C. Marbury;
- Jack W. Moncrief;
- Harry Alcorn Jr.;
- Suzanne Swan;
- Marshall R. Sack;
- Richard A. Robson;
- Kevin J. Petty;
- Jules I. Schwartz;
- Keith M. Gottesdiener
Publication type:
Article
An Evaluation of the Dose-Dependent Inhibition of CYP1A2 by Rofecoxib using Theophylline as a CYP1A2 Probe.
Published in:
Journal of Clinical Pharmacology, 2003, v. 43, n. 10, p. 1082, doi. 10.1177/0091270003257454
By:
- Bachmann, Kenneth;
- White, Donald;
- Jauregui, Luis;
- Schwartz, Jules I.;
- Agrawal, Nancy G. B.;
- Mazenko, Ralph;
- Larson, Patrick J.;
- Porras, Arturo G.
Publication type:
Article
Single- and Multiple-Dose Pharmacokinetics of Etoricoxib, a Selective Inhibitor of Cyclooxygenase-2, in Man.
Published in:
Journal of Clinical Pharmacology, 2003, v. 43, n. 3, p. 268, doi. 10.1177/0091270003251122
By:
- Agrawal, Nancy G.B.;
- Porras, Arturo G.;
- Matthews, Catherine Z.;
- Rose, Mark J.;
- Woolf, Eric J.;
- Musser, Bret J.;
- Dynder, Andrea L.;
- Mazina, Katherine E.;
- Lasseter, Kenneth C.;
- Hunt, Thomas L.;
- Schwartz, Jules I.;
- McCrea, Jacqueline B.;
- Gottesdiener, Keith M.
Publication type:
Article
Effect of Rofecoxib on Prednisolone and Prednisone Pharmacokinetics in Healthy Subjects.
Published in:
Journal of Clinical Pharmacology, 2003, v. 43, n. 2, p. 187, doi. 10.1177/0091270002239828
By:
- Schwartz, Jules I.;
- Mukhopadhyay, Saurabh;
- Porras, Arturo G.;
- Viswanathan-Aiyer, Kala-Jyoti;
- Adcock, Sherilyn;
- Ebel, David L.;
- Gertz, Barry J.
Publication type:
Article
Effect of Rofecoxib on the Pharmacokinetics of Chronically Administered Oral Contraceptivesin Healthy Female Volunteers.
Published in:
Journal of Clinical Pharmacology, 2002, v. 42, n. 2, p. 215, doi. 10.1177/009127000204200212
By:
- Schwartz, Jules I.;
- Wong, Peggy H.;
- Porras, Arturo G.;
- Ebel, David L.;
- Hunt, Thomas R.;
- Gertz, Barry J.
Publication type:
Article
Lack of Pharmacokinetic Interaction between Rofecoxib and Methotrexate in Rheumatoid Arthritis Patients.
Published in:
Journal of Clinical Pharmacology, 2001, v. 41, n. 10, p. 1120, doi. 10.1177/009127000104101011
By:
- Schwartz, Jules I.;
- Agrawal, Nancy G. B.;
- Wong, Peggy H.;
- Bachmann, Kenneth A.;
- Porras, Arturo G.;
- Miller, Jutta L.;
- Ebel, David L.;
- Sack, Marshall R.;
- Holmes, Gregory B.;
- Redfern, Jan S.;
- Gertz, Barry J.
Publication type:
Article
Effect of Rofecoxib on the Pharmacokinetics of Digoxin in Healthy Volunteers.
Published in:
Journal of Clinical Pharmacology, 2001, v. 41, n. 1, p. 107, doi. 10.1177/009127000104100i113
By:
- Schwartz, Jules I.;
- De Smet, Marina;
- Larson, Pat J.;
- R., Verbesselt;
- Ebel, David L.;
- Lins, Robert;
- Lens, Simonne;
- Porras, Arturo G.;
- Gertz, Barry J.
Publication type:
Article
Comparative Inhibitory Activity of Rofecoxib, Meloxicam, Diclofenac, Ibuprofen, and Naproxen on COX-2 versus COX-1 in Healthy Volunteers.
Published in:
Journal of Clinical Pharmacology, 2000, v. 40, n. 10, p. 1109, doi. 10.1177/009127000004001005
By:
- Van Hecken, Anne;
- Schwartz, Jules I.;
- Depré, Marleen;
- De Lepeleire, Inge;
- Dallob, Aimee;
- Tanaka, Wesley;
- Wynants, Kathleen;
- Buntinx, Agnes;
- Arnout, Jef;
- Wong, Peggy H.;
- Ebel, David L.;
- Gertz, Barry J.;
- De Schepper, Paul J.
Publication type:
Article
Effect of Multiple Doses of Rifampin on the [14C N-methyl] Erythromycin Breath Test in Healthy Male Volunteers.
Published in:
1998
By:
- Gharaibeh, Munir N.;
- Gillen, Lisa P.;
- Osborne, Barbara;
- Schwartz, Jules I.;
- Waldman, Scott A.
Publication type:
Other
Novel Oral Medication Delivery System for Famotidine.
Published in:
1995
By:
- Schwartz, Jules I.;
- Yeh, Kuang C.;
- Berger, Marc L.;
- Tomasko, Lisa;
- Hoover, Monica E.;
- Ebel, David L.;
- Stauffer, Laura A.;
- Han, Ronald;
- Bjornsson, Thorir D.
Publication type:
Other
Effects of Multiple Doses of Clarithromycin on the Pharmacokinetics of Laropiprant in Healthy Subjects.
Published in:
Cardiovascular Therapeutics, 2011, v. 29, n. 2, p. 140, doi. 10.1111/j.1755-5922.2009.00129.x
By:
- Wang, Ying-Hong;
- Schwartz, Jules I.;
- Luo, Wen-Lin;
- Jumes, Patricia;
- Desai, Rajesh;
- Wenning, Larissa A.;
- Wagner, John A.;
- Lai, Eseng
Publication type:
Article
Effects of Laropiprant, a Selective Prostaglandin D2 Receptor 1 Antagonist, on the Pharmacokinetics of Rosiglitazone.
Published in:
Cardiovascular Therapeutics, 2009, v. 27, n. 4, p. 239, doi. 10.1111/j.1755-5922.2009.00104.x
By:
- Schwartz, Jules I.;
- Stroh, Mark;
- Bing Gao;
- Fang Liu;
- Rosko, Kimberly;
- Zajic, Stefan;
- Meehan, Alan J.;
- Ruckle, Jon;
- Eseng Lai;
- Wagner, John A.
Publication type:
Article

Found: 26

The Effect of Erythromycin on the Disposition Kinetics of Warfarin.

Inhibition of prostacyclin and thromboxane biosynthesis in healthy volunteers by single and multiple doses of acetaminophen and indomethacin.

Comparative Pharmacokinetics of Lovastatin, Simvastatin and Pravastatin in Humans.

The bioavailability and nonlinear pharmacokinetics of MK-679 in humans.

The effect of rofecoxib on the pharmacodynamics and pharmacokinetics of warfarin<sup>*</sup>.

Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans<sup>*</sup>.

Pharmacodynamics of MK-0963, a new 5α-reductase inhibitor: Effects on serum androgen concentrations.

Effect of MK-386, a Novel Inhibitor of Type 15~ Reductase, Alone and in Combination with Finasteride, on Serum Dihydrotestosterone Concentrations in Men.

Evaluation of the pharmacokinetics of digoxin in healthy subjects receiving etoricoxib.

Pharmacokinetic Evaluation of Rofecoxib: Comparison of Tablet and Suspension Formulations.

Examination of the Effect of Increasing Doses of Etoricoxib on Oral Methotrexate Pharmacokinetics in Patients With Rheumatoid Arthritis.

Influence of Taranabant, an Orally Active, Highly Selective, Potent Cannabinoid-1 Receptor (CB1R) Inverse Agonist, on Ethinyl Estradiol and Norelgestromin Plasma Pharmacokinetics.

Comparative Inhibitory Activity of Etoricoxib, Celecoxib, and Diclofenac on COX-2 Versus COX-1 in Healthy Subjects.

Effects of Etoricoxib and Comparator Nonsteroidal Anti-Inflammatory Drugs on Urinary Sodium Excretion, Blood Pressure, and Other Renal Function Indicators in Elderly Subjects Consuming a Controlled Sodium Diet.

Pharmacokinetics of Etoricoxib in Patients with Renal Impairment.

An Evaluation of the Dose-Dependent Inhibition of CYP1A2 by Rofecoxib using Theophylline as a CYP1A2 Probe.

Single- and Multiple-Dose Pharmacokinetics of Etoricoxib, a Selective Inhibitor of Cyclooxygenase-2, in Man.

Effect of Rofecoxib on Prednisolone and Prednisone Pharmacokinetics in Healthy Subjects.

Effect of Rofecoxib on the Pharmacokinetics of Chronically Administered Oral Contraceptivesin Healthy Female Volunteers.

Lack of Pharmacokinetic Interaction between Rofecoxib and Methotrexate in Rheumatoid Arthritis Patients.

Effect of Rofecoxib on the Pharmacokinetics of Digoxin in Healthy Volunteers.

Comparative Inhibitory Activity of Rofecoxib, Meloxicam, Diclofenac, Ibuprofen, and Naproxen on COX-2 versus COX-1 in Healthy Volunteers.

Effect of Multiple Doses of Rifampin on the [<sup>14</sup>C N-methyl] Erythromycin Breath Test in Healthy Male Volunteers.

Novel Oral Medication Delivery System for Famotidine.

Effects of Multiple Doses of Clarithromycin on the Pharmacokinetics of Laropiprant in Healthy Subjects.

Effects of Laropiprant, a Selective Prostaglandin D<sub>2</sub> Receptor 1 Antagonist, on the Pharmacokinetics of Rosiglitazone.